Home Halogens 2,3-Dichloroquinoxaline

2,3-Dichloroquinoxaline

CAS No.:
2213-63-0
Catalog Number:
AG0032XQ
Molecular Formula:
C8H4Cl2N2
Molecular Weight:
199.0368
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5g
95%
In Stock USA
United States
$15
- +
25g
95%
In Stock USA
United States
$44
- +
100g
95%
In Stock USA
United States
$150
- +
500g
95%
In Stock USA
United States
$563
- +
Product Description
Catalog Number:
AG0032XQ
Chemical Name:
2,3-Dichloroquinoxaline
CAS Number:
2213-63-0
Molecular Formula:
C8H4Cl2N2
Molecular Weight:
199.0368
MDL Number:
MFCD00006720
IUPAC Name:
2,3-dichloroquinoxaline
InChI:
InChI=1S/C8H4Cl2N2/c9-7-8(10)12-6-4-2-1-3-5(6)11-7/h1-4H
InChI Key:
SPSSDDOTEZKOOV-UHFFFAOYSA-N
SMILES:
Clc1nc2ccccc2nc1Cl
EC Number:
218-667-3
NSC Number:
33437
UN Number:
2811
Properties
Complexity:
147  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
197.975g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
199.034g/mol
Monoisotopic Mass:
197.975g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
25.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
3.1  
Literature
Title Journal
AlCl3 induced (hetero)arylation of 2,3-dichloroquinoxaline: a one-pot synthesis of mono/disubstituted quinoxalines as potential antitubercular agents. Bioorganic & medicinal chemistry 20120301
Part I: Synthesis, cancer chemopreventive activity and molecular docking study of novel quinoxaline derivatives. European journal of medicinal chemistry 20110101
Synthesis of some new pyrimido[2',1':2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents. European journal of medicinal chemistry 20100501
Synthesis, structure elucidation and antibacterial evaluation of new steroidal -5-en-7-thiazoloquinoxaline derivatives. European journal of medicinal chemistry 20081001
Synthesis, characterization and in vitro antibacterial activity of new steroidal 5-en-3-oxazolo and thiazoloquinoxaline. European journal of medicinal chemistry 20080901
Syntheses and evaluation of 3-(3-bromo phenyl)-5-phenyl-1-(thiazolo [4,5-b] quinoxaline-2-yl)-2-pyrazoline derivatives. European journal of medicinal chemistry 20080801
3-Ethyl-sulfanyl-5-methyl-1-phenyl-7-(pyrrolidin-1-yl)-1H-pyrimido[4,5-e][1,3,4]thia-diazine. Acta crystallographica. Section E, Structure reports online 20080801
Synthesis of heterocyclic compounds via nucleophilic aroylation catalyzed by imidazolidenyl carbene. Chemical & pharmaceutical bulletin 20061201
From bifunctional nucleophilic behavior of DBU to a new heterocyclic fluorescent platform. Organic letters 20061012
Synthesis, characterization and antiamoebic activity of 1-(thiazolo[4,5-b]quinoxaline-2-yl)-3-phenyl-2-pyrazoline derivatives. Bioorganic & medicinal chemistry letters 20060515
An air-stable P-chiral phosphine ligand for highly enantioselective transition-metal-catalyzed reactions. Journal of the American Chemical Society 20050831
8,19-Dimethyl-8,19-dihydro-8,19-ethanoanthra[2'',3'':2,3;6'',7'':2',3']di-1,4-dioxino[5,6-b;5',6'-b']diquinoxaline. Acta crystallographica. Section C, Crystal structure communications 20041101
Properties